A Mitochondrial Protein May Hold the Secret to Longevity

Researchers from the Tokyo Metropolitan Institute for Geriatrics and Gerontology have identified a mitochondrial protein that may play an important role in healthy aging. The study focuses on COX7RP, a protein involved in organizing mitochondrial respiratory supercomplexes, structures that improve cellular energy production efficiency.

Mitochondria are central to aging biology because they produce ATP, the energy required for cellular function. Declining mitochondrial performance is strongly associated with aging and age-related diseases. By increasing COX7RP levels in experimental models, researchers were able to improve mitochondrial efficiency, enhance metabolic health, and extend lifespan in mice.

The findings suggest that longevity may depend not only on metabolic activity itself, but on how efficiently mitochondrial systems are organized and coordinated. Respiratory supercomplexes appear to optimize electron transfer and reduce oxidative stress, helping cells maintain energy balance over time.

This work reinforces a growing idea in longevity science: aging is closely linked to the progressive decline of mitochondrial function and biological coordination. Improving mitochondrial organization and efficiency may therefore represent a promising strategy for extending healthspan.

The study also highlights how mitochondrial architecture, metabolism, and redox balance interact to influence aging trajectories, themes that resonate strongly with the systems-biology perspective explored at Targeting Longevity.

The World Mitochondria Society will organize 2 meetings dedicated to mitochondria dynamics next April & October.

Image Credit

Title: Exploring the link between COX7RP, a mitochondrial protein, and longevity
Caption: In a new study, researchers from Japan demonstrate that COX7RP, a mitochondrial protein, may play a key role in enhancing mitochondrial energy efficiency, leading not only to longer lifespans but also an extended "healthspan" via numerous health benefits.
Credit: Dr. Satoshi Inoue from Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan

Referance

Ikeda, K., S.Shiba, M.Yokoyama, et al. 2026. "Mitochondrial Respiratory Supercomplex Assembly Factor COX7RP Contributes to Lifespan Extension in Mice." Aging Cell25, no. 1: e70294. https://doi.org/10.1111/acel.70294.

Read the full article 

Exercise May Help the Brain Heal After Stroke

New research shows movement can send energy to damaged brain cells, opening new doors for therapy

Exercise has long been known to help people recover after stroke. Now scientists have found a possible reason why. A new study shows that physical activity may help the body deliver energy directly to injured parts of the brain, supporting repair and recovery.

The research suggests exercise is not only training muscles or improving balance. It may activate a natural healing process inside the body that helps brain cells survive and function after injury.

What they did

Researchers studied stroke in mice to closely observe what happens inside the body during recovery. They divided the animals into two groups. One group exercised regularly. The other group did not.

The scientists focused on mitochondria, the parts of cells that produce energy. They measured mitochondria in muscles, blood, and brain tissue.

They found that exercise increased the number of mitochondria in the blood. Platelets then carried these mitochondria through the bloodstream. After stroke, the mitochondria traveled into damaged areas of the brain and entered brain cells.

The researchers also tested movement, memory, and brain structure. Mice that exercised had less damage to brain tissue and performed better on recovery tests.

Why it matters

Stroke treatment options are limited. Emergency care can restore blood flow, but long term brain repair remains difficult. Rehabilitation depends largely on repeated physical practice.

This study adds a new layer of hope. It suggests exercise may work as a biological therapy, helping the brain at a cellular level, not only through practice and training.

Impact

The findings point to a new way of thinking about recovery. Exercise may act as a delivery system, sending energy from the body to the injured brain. This could help explain why movement improves outcomes even weeks or months after stroke.

The research also raises important questions. Could future therapies copy the benefits of exercise for patients who cannot move easily? Could similar approaches help people with dementia or other brain conditions?

Perspective

The study was done in animals, not humans, and more research is needed before clinical use. But the message is optimistic and grounded in biology.

The body is not passive after injury. With movement, it may activate its own repair tools.

Exercise may be more than rehabilitation. It may be part of the medicine itself.

These findings resonate strongly with the spirit of Targeting Mitochondria 2026, where dynamism is the central concept.
They remind us that health and recovery are not static processes, but living, energy-driven dialogues between organs, cells, and systems.

At TM2026, scientists, clinicians, and innovators will explore how movement, energy transfer, and mitochondrial intelligence can reshape our understanding of therapy from stroke recovery to neurodegeneration, aging, and resilience.

This study reinforces a simple but powerful idea: when biology moves, healing follows.
And sometimes, the most effective therapies begin not with drugs, but with restoring the natural dynamics of life itself. 

References & Image Credits:

T.Inaba, N.Miyamoto, K.Hira, et al. “Mitochondrial Intercellular Transfer via Platelets After Physical Training Exerts Neuro-Glial Protection Against Cerebral Ischemia.” MedComm7, no. 2 (2026): e70590. https://doi.org/10.1002/mco2.70590

Image title: Exercise-induced mitochondria aid recovery from cerebral ischemia
Image caption: Researchers have demonstrated how mitochondria, which are abundant in muscle, could aid in stroke recovery through exercise-induced migration.
Image credit: Dr. Toshiki Inaba, Juntendo University School of Medicine, Japan

Read the full article

We are pleased to announce that the 17th Conference Targeting Mitochondria 2026 will be held in Berlin, Germany, from October 21-23. We look forward to welcoming you.

Sugar first, mitochondria later: how brain immune cells respond to injury

When the brain is injured, its immune cells don’t wait around. New research reveals that microglia, the brain’s resident immune cells, launch their first response using sugar-based energy, long before mitochondria enter the scene.

Using advanced live imaging, scientists observed that microglia rush toward damage and begin their work almost immediately even though their long cellular extensions contain few or no mitochondria at this early stage. Instead, these cells rely on glycolysis, a fast way to generate energy from sugar, allowing them to move quickly and react within minutes.

Only later do mitochondria arrive. Hours after the initial response, microglia reorganize their internal architecture, building microscopic transport routes that allow mitochondria to travel to the most active zones. Once there, mitochondria support sustained functions such as debris clearance and longer-term immune activity.

This two-step strategy challenges the traditional view of mitochondria as constant power suppliers. Instead, it shows that brain immune cells are metabolically flexible, choosing speed first and endurance second.

Why this matters: microglia play a central role in aging, neuroinflammation, and neurodegenerative diseases. Understanding how healthy microglia manage energy over time helps researchers identify what may go wrong in chronic brain disorders and how mitochondrial function might be restored or optimized.

In short, the brain’s immune response is not only fast it is smart, adaptive, and precisely timed.

The World Mitochondria Society will organize 2 meetings dedicated to mitochondria dynamics next April & October. 

References

Pietramale, A.N., Bame, X., Doty, M.E. et al. Mitochondria are absent from microglial processes performing surveillance, chemotaxis, and phagocytic engulfment. Nat Commun16, 11104 (2025). https://doi.org/10.1038/s41467-025-66708-6

Read the full article.

Will Future Medicine Transplant Organelles Instead of Organs?

Mitochondrial transplantation is emerging as a potential new strategy to restore cellular energy and repair damaged tissues.

For decades, medicine has replaced failing organs through transplantation. But a new scientific idea is beginning to reshape biomedical thinking: what if we could repair cells by replacing their organelles instead of entire organs?

At the center of this emerging concept are mitochondria, the organelles responsible for producing cellular energy and regulating metabolism, oxidative stress, and cell survival. Mitochondrial dysfunction is now recognized as a central component of many diseases, including neurodegeneration, metabolic disorders, ischemic injury, and inflammatory conditions.

Recent experimental work has begun to clarify how cells interact with transplanted mitochondria. Researchers studying mesenchymal stromal cells demonstrated that isolated mitochondria can be actively internalized by recipient cells, rather than remaining outside the cell.

Once internalized, these mitochondria remain metabolically active and enhance key cellular functions. The study showed increases in oxygen consumption, ATP production, and resistance to oxidative stress, indicating improved cellular bioenergetics. 

Importantly, mitochondrial uptake occurs through energy-dependent endocytic pathways, including dynamin-mediated and lipid-raft–associated mechanisms. These findings suggest that mitochondrial incorporation is an active biological process rather than a passive event. 

A Strategic Topic for Future Mitochondrial Medicine

The concept of mitochondrial transplantation reflects a broader transformation in biomedical thinking: mitochondria are no longer viewed only as metabolic organelles but as therapeutic targets and potential therapeutic agents.

For this reason, mitochondrial transfer and mitochondrial-based therapies will be one of the strategic themes discussed at the upcoming Targeting Mitochondria 2026 meeting, organized by the World Mitochondria Society in Berlin.

The meeting will explore several emerging directions in mitochondrial medicine, including:

• Mitochondrial transplantation and organelle therapy
• Mitochondrial communication with microbiota and immune systems
• Extracellular vesicles as carriers of mitochondrial signals
• Metabolic resilience and aging
• Mitochondrial dysfunction in neurodegeneration and chronic disease

Understanding how mitochondria move between cells, integrate into recipient tissues, and influence cellular metabolism may redefine how medicine approaches diseases driven by energy failure.

Implications for Medicine

Because mitochondrial dysfunction contributes to numerous diseases, mitochondrial transplantation could potentially impact several fields:

• Neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease
• Stroke and ischemia–reperfusion injury
• Metabolic diseases
• Inflammatory and immune disorders

In neuroscience, experimental studies are already exploring whether delivering mitochondria to damaged neurons could protect brain cells and improve recovery after injury.

Toward Organelle-Based Medicine

Traditional therapies target molecules or genes. Mitochondrial transplantation proposes something fundamentally different: restoring cellular function by supplying intact bioenergetic organelles.

Interestingly, biology already supports this possibility. Cells can naturally exchange mitochondria through tunneling nanotubes and extracellular vesicles, suggesting that organelle transfer may be part of natural repair mechanisms.

If these processes can be controlled and scaled, medicine may eventually move toward a new paradigm: organelle-based therapies.

The Questions That Will Shape the Field

Despite its promise, mitochondrial transplantation remains an emerging concept. Several scientific challenges remain:

• How efficiently can transplanted mitochondria integrate into tissues?
• How long do transplanted mitochondria remain functional?
• Can mitochondrial delivery become safe, scalable, and standardized?
• What regulatory frameworks will govern organelle-based therapies?

Answering these questions will determine whether mitochondrial transplantation becomes a cornerstone of regenerative medicine.

If successful, future therapies might not only repair genes or proteins.

They might restore the energy systems of the cell itself.

References

Kanai, M., Goto, M., Itakura, S. et al. Uptake mechanisms and functions of isolated mitochondria in mesenchymal stromal cells. Sci Rep15, 44799 (2025). https://doi.org/10.1038/s41598-025-28494-5

Read the full article